Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Science › John Malone Floats Potential Deal Between Skydance and SpaceX
Science

John Malone Floats Potential Deal Between Skydance and SpaceX

Bloomberg Markets Wednesday 21 October 2026, 16:26 UTC By Hannah Miller 1 min read
Key Points

John Malone Floats Potential Deal Between Skydance and SpaceX Media mogul John Malone said he thinks there could be a deal coming between Skydance Corp. and Elon Musk’s SpaceX. Speaking at the Paley International Council Summit in New York on Wednesday, Malone said SpaceX could potentially invest $8 billion to $10 billion in Skydance, according to the Hollywood Reporter.

John Malone Floats Potential Deal Between Skydance and SpaceX Media mogul John Malone said he thinks there could be a deal coming between Skydance Corp. and Elon Musk’s SpaceX. Speaking at the Paley International Council Summit in New York on Wednesday, Malone said SpaceX could potentially invest $8 billion to $10 billion in Skydance, according to the Hollywood Reporter.
John Malone Floats (PERSON) Skydance (ORG) SpaceX (ORG) SpaceX Media (ORG) John Malone (PERSON) Skydance Corp. (ORG) Elon Musk’s (PERSON) the Paley International Council Summit (ORG) New York (LOCATION) Malone (PERSON) Hollywood (LOCATION)
Originally published by Bloomberg Markets Read original →

Related Stories

Controversial US-backed vaccine trial in African newborns halted

Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It is “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.”

The Guardian UK 20m ago

Controversial US-backed vaccine trial in African newborns halted

Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It is “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.”

The Guardian World 20m ago

Controversial US-backed vaccine trial in African newborns halted

Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It is “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.”

The Guardian Health 20m ago

Man with a PhD and Nobel-cited research has sent out 2,300 applications yet cannot land a job

Man with a PhD and Nobel-cited research has sent out 2,300 applications yet cannot land a job Despite unemployment hovering between 3.5 percent and 4.3 percent over the past three years, applicants say finding work remains difficult - Bookmark - CommentsGo to comments Become an Independent member to bookmark this article Already a member? Log in A Princeton University graduate, whose research was cited by the Nobel committee, says he has applied for more than 2,300 jobs since earning his...

The Independent World 23m ago